middle.news

How Will BCAL’s $10M Convertible Note Boost Cancer Detection Progress?

9:59am on Monday 20th of October, 2025 AEDT Biotechnology
Read Story

How Will BCAL’s $10M Convertible Note Boost Cancer Detection Progress?

9:59am on Monday 20th of October, 2025 AEDT
Key Points
  • Convertible note facility up to $10 million for working capital
  • Firm commitments received for $5 million
  • Facility subject to shareholder approval at November AGM
  • Notes convertible into shares at a discount with capped conversion price
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Bcal Diagnostics (ASX:BDX)
OPEN ARTICLE